G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors

Eun Young Choi, Dae Won Jeong, Kye Won Park, Ja-Hyun Baik

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Two isoforms of dopamine D2 receptor, D2L (long) and D2S (short), differ by the insertion of 29 amino acids specific to D2L within the putative third intracellular loop of the receptor, which appears to be important in selectivity for G-protein coupling. We have generated D2L- and D2S-expressing Chinese hamster ovary (CHO) cells, and regulation of the mitogen-activated protein kinase (MAPK) pathway was examined in these cells. Both D2L and D2S mediated a rapid and transient activation of MAPK with dominant activation of p42-kDa MAPK. Pertussis toxin treatment completely abrogated stimulation of MAPK mediated by D2L and D2S, demonstrating that both receptors couple to pertussis toxin-sensitive G proteins in this signaling. Stimulation of MAPK mediated by both D2L and D2S receptor was markedly attenuated by coexpression of the C-terminus of p-adrenergic receptor kinase (βARKct), which selectively inhibits Gβγ-mediated signal transduction. Further analysis of D2L- and D2S-mediated MAPK activation demonstrated that D2L-mediated MAPK activation was not significantly affected by PKC depletion or partially affected by genistein. In contrast, D2S-mediated MAPK activation was potentially inhibited by PKC depletion and genistein was capable of completely inhibiting D2S-mediated MAPK activation. Together, these results suggest that D2L- and D2S-mediated MAPK activation is predominantly Gβγ subunit-mediated signaling and that protein kinase C and tyrosine phosphorylations are involved in these signaling pathways.

Original languageEnglish
Pages (from-to)33-40
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume256
Issue number1
DOIs
Publication statusPublished - 1999 Mar 5
Externally publishedYes

Fingerprint

Dopamine D2 Receptors
Mitogen-Activated Protein Kinases
GTP-Binding Proteins
Chemical activation
Genistein
Pertussis Toxin
Mitogen-Activated Protein Kinase 1
Signal transduction
Phosphorylation
Cricetulus
Adrenergic Receptors
Protein Kinase C
Tyrosine
Ovary
Signal Transduction
Protein Isoforms
Phosphotransferases
Cells
Amino Acids

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors. / Choi, Eun Young; Jeong, Dae Won; Park, Kye Won; Baik, Ja-Hyun.

In: Biochemical and Biophysical Research Communications, Vol. 256, No. 1, 05.03.1999, p. 33-40.

Research output: Contribution to journalArticle

@article{d568f6f2f8124f0eb04e83ead962142f,
title = "G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors",
abstract = "Two isoforms of dopamine D2 receptor, D2L (long) and D2S (short), differ by the insertion of 29 amino acids specific to D2L within the putative third intracellular loop of the receptor, which appears to be important in selectivity for G-protein coupling. We have generated D2L- and D2S-expressing Chinese hamster ovary (CHO) cells, and regulation of the mitogen-activated protein kinase (MAPK) pathway was examined in these cells. Both D2L and D2S mediated a rapid and transient activation of MAPK with dominant activation of p42-kDa MAPK. Pertussis toxin treatment completely abrogated stimulation of MAPK mediated by D2L and D2S, demonstrating that both receptors couple to pertussis toxin-sensitive G proteins in this signaling. Stimulation of MAPK mediated by both D2L and D2S receptor was markedly attenuated by coexpression of the C-terminus of p-adrenergic receptor kinase (βARKct), which selectively inhibits Gβγ-mediated signal transduction. Further analysis of D2L- and D2S-mediated MAPK activation demonstrated that D2L-mediated MAPK activation was not significantly affected by PKC depletion or partially affected by genistein. In contrast, D2S-mediated MAPK activation was potentially inhibited by PKC depletion and genistein was capable of completely inhibiting D2S-mediated MAPK activation. Together, these results suggest that D2L- and D2S-mediated MAPK activation is predominantly Gβγ subunit-mediated signaling and that protein kinase C and tyrosine phosphorylations are involved in these signaling pathways.",
author = "Choi, {Eun Young} and Jeong, {Dae Won} and Park, {Kye Won} and Ja-Hyun Baik",
year = "1999",
month = "3",
day = "5",
doi = "10.1006/bbrc.1999.0286",
language = "English",
volume = "256",
pages = "33--40",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors

AU - Choi, Eun Young

AU - Jeong, Dae Won

AU - Park, Kye Won

AU - Baik, Ja-Hyun

PY - 1999/3/5

Y1 - 1999/3/5

N2 - Two isoforms of dopamine D2 receptor, D2L (long) and D2S (short), differ by the insertion of 29 amino acids specific to D2L within the putative third intracellular loop of the receptor, which appears to be important in selectivity for G-protein coupling. We have generated D2L- and D2S-expressing Chinese hamster ovary (CHO) cells, and regulation of the mitogen-activated protein kinase (MAPK) pathway was examined in these cells. Both D2L and D2S mediated a rapid and transient activation of MAPK with dominant activation of p42-kDa MAPK. Pertussis toxin treatment completely abrogated stimulation of MAPK mediated by D2L and D2S, demonstrating that both receptors couple to pertussis toxin-sensitive G proteins in this signaling. Stimulation of MAPK mediated by both D2L and D2S receptor was markedly attenuated by coexpression of the C-terminus of p-adrenergic receptor kinase (βARKct), which selectively inhibits Gβγ-mediated signal transduction. Further analysis of D2L- and D2S-mediated MAPK activation demonstrated that D2L-mediated MAPK activation was not significantly affected by PKC depletion or partially affected by genistein. In contrast, D2S-mediated MAPK activation was potentially inhibited by PKC depletion and genistein was capable of completely inhibiting D2S-mediated MAPK activation. Together, these results suggest that D2L- and D2S-mediated MAPK activation is predominantly Gβγ subunit-mediated signaling and that protein kinase C and tyrosine phosphorylations are involved in these signaling pathways.

AB - Two isoforms of dopamine D2 receptor, D2L (long) and D2S (short), differ by the insertion of 29 amino acids specific to D2L within the putative third intracellular loop of the receptor, which appears to be important in selectivity for G-protein coupling. We have generated D2L- and D2S-expressing Chinese hamster ovary (CHO) cells, and regulation of the mitogen-activated protein kinase (MAPK) pathway was examined in these cells. Both D2L and D2S mediated a rapid and transient activation of MAPK with dominant activation of p42-kDa MAPK. Pertussis toxin treatment completely abrogated stimulation of MAPK mediated by D2L and D2S, demonstrating that both receptors couple to pertussis toxin-sensitive G proteins in this signaling. Stimulation of MAPK mediated by both D2L and D2S receptor was markedly attenuated by coexpression of the C-terminus of p-adrenergic receptor kinase (βARKct), which selectively inhibits Gβγ-mediated signal transduction. Further analysis of D2L- and D2S-mediated MAPK activation demonstrated that D2L-mediated MAPK activation was not significantly affected by PKC depletion or partially affected by genistein. In contrast, D2S-mediated MAPK activation was potentially inhibited by PKC depletion and genistein was capable of completely inhibiting D2S-mediated MAPK activation. Together, these results suggest that D2L- and D2S-mediated MAPK activation is predominantly Gβγ subunit-mediated signaling and that protein kinase C and tyrosine phosphorylations are involved in these signaling pathways.

UR - http://www.scopus.com/inward/record.url?scp=0033525899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033525899&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1999.0286

DO - 10.1006/bbrc.1999.0286

M3 - Article

VL - 256

SP - 33

EP - 40

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 1

ER -